Tipranks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry now
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock Comparison5g StocksAirline StocksArtificial Intelligence StocksBank StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChinese StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksCybersecurity StocksElectric Vehicle StocksFAANG StocksGold StocksGrowth StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksRenewable Energy StocksSolar StocksSpace StocksStay-At-Home StocksTech StocksUtility StocksVideo Game StocksVirtual Reality StocksWallStreetBets StocksWork-From-Home Stocks
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology Stock Analysis & Ratings
Vir Biotechnology Stock Analysis Overview
Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
ANALYST RATINGS
CONSENSUS
Moderate Buy
Average Price Target : $138.67
BLOGGER OPINIONS
SENTIMENT
Bullish
VIR Sentiment 100% Sector Average 71%
HEDGE FUND ACTIVITY
TREND
▲ Increased
By 482.8K Shares Last Quarter.
INSIDER ACTIVITY
TREND
▼ Sold Shares
Worth $21.0M over the Last 3 Months
TIPRANKS INVESTORS
SENTIMENT
Very Positive
Last 7 Days ▼2.1% Last 30 Days ▲4.2%
NEWS SENTIMENT
LAST 7 DAYS
Very Bearish
Bullish 0% Bearish 100%
TECHNICALS
SMA
Negative
20 days / 200 days
MOMENTUM
-42.15%
12 Months Change
FUNDAMENTALS
RETURN ON EQUITY
-12.12%
Trailing 12 Months
ASSET GROWTH
28.30%
Trailing 12 Months
VIR Stock Stats
Previous Close$31.26
Open$31.56
Bid0 x 0
Ask0 x 0
Today’s Range$30.6 - $34.06
52-Week Range$29.48 - $83.50
Volume1.17M
Average Volume1.51M
Market Cap$4.45B
Beta-1.54
P/E Ratio-39.3
EPS-0.86
Earnings DateMar 31, 2022
1Y Price Target$138.67
Company Description
Vir Biotechnology
Financials
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
Vir Biotechnology News
VIR FAQ
What was Vir Biotechnology’s price range in the past 12 months?
Vir Biotechnology lowest stock price was $29.48 and its highest was $83.50 in the past 12 months.
What is Vir Biotechnology’s market cap?
Vir Biotechnology’s market cap is $4.45B.
What is Vir Biotechnology’s price target?
The average price target for Vir Biotechnology is $138.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $300.00 ,the lowest forecast is $36.00. The average price target represents 308.21% Increase from the current price of $33.97.
The highest analyst price target is $300.00 ,the lowest forecast is $36.00. The average price target represents 308.21% Increase from the current price of $33.97.
What do analysts say about Vir Biotechnology?
Vir Biotechnology’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
When is Vir Biotechnology’s upcoming earnings report date?
Vir Biotechnology’s upcoming earnings report date is Mar 31, 2022 which is in 61 days.
How were Vir Biotechnology’s earnings last quarter?
Vir Biotechnology released its earnings results on Nov 04, 2021. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of -$0.048 by $0.868.
Is Vir Biotechnology overvalued?
According to Wall Street analysts Vir Biotechnology’s price is currently Undervalued.
Does Vir Biotechnology pay dividends?
Vir Biotechnology does not currently pay dividends.
What is Vir Biotechnology’s EPS estimate?
Vir Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vir Biotechnology have?
Vir Biotechnology has 130,880,000 shares outstanding.
What happened to Vir Biotechnology’s price movement after its last earnings report?
Vir Biotechnology reported an EPS of $0.82 in its last earnings report, beating expectations of -$0.048. Following the earnings report the stock price went down -15.054%.
Which hedge fund is a major shareholder of Vir Biotechnology?
Among the largest hedge funds holding Vir Biotechnology’s share is Oracle Investment Management Inc. It holds Vir Biotechnology’s shares valued at 51M.